Foundation Medicine Announces $42.5m in Series B Financing

September 20, 2012

September 20, 2012 | Foundation Medicine announced a $42.5 million Series B financing round this morning thanks to Deerfield Management Company, L.P., Casdin Capital, Redmile Group and strategic investors Roche Venture Fund and WuXi Corporate Venture Fund. One undisclosed fund and one undisclosed strategic investor also involved in this financing round. For a closer look at Foundation Medicine's next generation cancer diagnostic technologies, see Laying the Foundation for Next-Gen Cancer Diagnostics. Boston Globe